sodium salicylate has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, KE; Haycock, JW; Hill, RP; Katerinaki, E; Lalla, R; Lorigan, PC; MacNeil, S; Yang, Y | 1 |
| Furukawa, M; Murono, S; Pagano, JS; Sato, H; Takeshita, H; Yoshizaki, T | 1 |
2 other study(ies) available for sodium salicylate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Sodium salicylate inhibits TNF-alpha-induced NF-kappaB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells.
Topics: Cell Movement; Fibronectins; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Luciferases; Melanoma; Neoplasm Invasiveness; NF-kappa B; Promoter Regions, Genetic; Skin Neoplasms; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation | 2006 |
Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Topics: Animals; Aspirin; Blotting, Western; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Enzyme Inhibitors; Humans; I-kappa B Kinase; I-kappa B Proteins; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Plasmids; Promoter Regions, Genetic; Protein Binding; Protein Serine-Threonine Kinases; Sodium Salicylate; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured; Viral Matrix Proteins | 2000 |